2018 Stanford Drug Discovery Conference
Palo Alto, California
9:0am - 5:0pm
This exciting meeting will include presentations from leaders of major pharmaceutical companies, federal and foundation policy makers, editors from major biomedical publications, and scientists making groundbreaking advances in the drug discovery space. Highlights of the agenda include a keynote address by Dr. Brian Kobilka, Helene Irwin Fagan Chair in Cardiology & Professor in Physiology and winner of the Nobel Prize for Chemistry (2012), the presentation of a Lifetime Achievement Award to Dr. Roy Vagelos (former CEO of Merck and current Chair of Regeneron) and presentations from the leaders of Merck, Novartis, Allergan, NantWorks, and Amgen during a “View from the Top” session. The second day will feature a Shark-Tank style competition in which researchers engaged in clinical and translational projects will have the opportunity to present their ideas to a panel of CEO judges. Lastly, the closing keynote address will be given by Dr. Janet Woodcock, the Director of the FDA’s Center for Drug Evaluation and Research, who promises to provide important insight into changes in the New Drug Regulatory Program.
The symposium is co-sponsored by the Stanford Cardiovascular Institute (CVI) and the Stanford Cancer Institute (SCI).
Contact: Sanjay Malhotra
Contact Phone: 650-736-9231
Contact Email: firstname.lastname@example.org
Paul Berg Hall,
Li Ka Shing Conference Center